Let's See if We Get the Hat Trick

With BLUE and JUNO both sprinting higher this morning, the only thing missing now to complete our "hat trick" of a triple breakout from our big three biotechs on watch would be to see ESPR sustain a move higher.

Indeed, with many biotech and energy/materials stocks squeezing this morning, not to mention beaten-down names like YELP we have been noting as squeeze candidates, ESPR may be as actionable as anything here as it has yet to run away to the upside. 

On the updated daily chart, below, you can see the tight triangle threatening to resolve higher.

$107.70, then $110 are my upside levels of note to likely get the stock going.